Related Experiment Video
Updated: May 25, 2025
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
6.7K
[Usefulness of the thrombin generation test in hypercoagulability states]
Paul Billoir1, Sébastien Miranda2, Hervé Lévesque2
1Service d'Hématologie Biologique, Centre hospitalier Universitaire Charles Nicolle, 1 rue de Germont, 76031 Rouen, France.
Annales De Biologie Clinique
|February 26, 2025
Summary
The thrombin generation assay (TGA) can assess bleeding and clotting risks. Harmonizing TGA methods could improve prediction of thrombotic events in various conditions.
Area of Science:
- Coagulation science
- Hemostasis research
- Thrombosis and bleeding risk assessment
Background:
- Thrombin is central to hemostasis and coagulation.
- The thrombin generation assay (TGA) evaluates coagulation dynamics.
- TGA is valuable for assessing bleeding and thrombosis risks.
Purpose of the Study:
- To systematically review studies on thrombinography in thrombophilia.
- To evaluate the utility of TGA in various thrombotic conditions.
Main Methods:
- Systematic review of original investigations using TGA.
- Studies published in English between January 2003 and June 2022.
- Included conditions: venous thromboembolism, arterial disease, pregnancy, antiphospholipid syndrome, constitutional thrombophilias, oncology.
Main Results:
- Eighty studies were selected; most had <100 patients.
- Two large studies (>1000 patients) linked increased thrombin generation to higher thrombotic recurrence or cardiovascular mortality.
- All thrombophilia conditions have been studied using TGA.
Conclusions:
- Lack of standardization in TGA hinders clinical research development.
- Harmonizing TGA practices may enhance prediction of arterial and venous thrombotic events.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
592
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
592
01:24Disorders of Hemostasis
679
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
679
01:16Clot Retraction and Fibrinolysis
3.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.8K
01:09Coagulation
4.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.2K